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Abstract
Background: Structured care is proposed as a lever for improving care for patients with chronic
conditions. The purpose of this study was to explore the associations of structured care
characteristics, derived from the Chronic Care Model, with health-related quality of life (HRQOL)
and optimal clinical management in chronic heart failure (CHF) patients in primary care, as well as
the association between optimal management and HRQOL.
Methods: Cross-sectional observational study using multi-level random-coefficient analyses of a
representative sample of 357 patients diagnosed with CHF from 42 primary care practices in the
Netherlands. We combined individual medical record data with patient and physician
questionnaires.
Results: There was large variation in the levels and presence of structured care elements. A 91%
of physicians indicated that next appointments for CHF patients were made immediately after visits,
while 11% indicated that reminders on CHF management were periodically received in their
practice. Few associations were found between the organizational characteristics and optimal
treatment or HRQOL. Optimal pharmacological treatment related to better quality of life (β = -
11.5, P < .0001). Also, more lifestyle advice was given in practices with an appointment system
allowing contact with more than one professional during the encounter (β = 1.0, P = .04).
Conclusion: HRQOL and treatment quality in CHF patients were not consistently associated with
characteristics of structured care in primary care practices.
Background
In high-income countries, the prevalence of chronic heart
failure (CHF) is estimated to be 1–2% [1], and expecta-
tions are that this figure will be rising as survival of acute
heart disease is increasing [1,2]. CHF has high hospital
admission rates [3], and severely compromises health-
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related quality of life (HRQOL) [4]. Many CHF patients
are managed in primary care, but research on organiza-
tion of primary care for CHF is limited. Guidelines on the
management of CHF recommend pharmacological treat-
ment to deal with heart failure symptoms and to reduce
morbidity and mortality in nearly all patients: in particu-
lar ACE inhibitors (ACEI) or angiotensin-II receptor
blockers (ARB) and β-blockers [5-7]. In addition, clinical
guidelines [5-7] incorporate principles of structured
chronic care such as patient counselling on self manage-
ment to promote continuity of care. Patients are to be
monitored regularly with (daily) body weight measure-
ments and are to receive lifestyle advice, such as reducing
salt intake, limiting fluid intake, exercise, and resting peri-
ods.
The goal of guidelines is to improve the survival and qual-
ity of life of patients in daily life. Consistently, studies
show suboptimal adherence to guidelines in management
of heart failure, especially in primary care [8,9]. There is a
growing belief that structural support at the organiza-
tional level is needed to enhance guideline implementa-
tion [10-12]. Structured chronic care is considered
increasingly important to optimize clinical management
of patients with chronic diseases [13,14]. Studies in diabe-
tes indicated that the level of the organizations' use of
physician reminders [15], performance feedback [15,16],
involvement of patients in defining treatment goals [16],
patient education [17] and structured care management
[15,16] is positively associated with better outcomes.
There is evidence that improvements in health care deliv-
ery improve health outcomes as HRQOL and limit the
need for hospitalizations as well as improve prescribing
practices for patients with chronic heart failure [13,18-
22]. However, little is known about the relationship
between the presence of these elements and indicators of
quality of CHF care in primary care. Such insight is impor-
tant, since it may guide the design of future practice mod-
els for heart failure care to improve HRQOL in CHF
patients.
In this study we explored the extent to which structured
chronic care features, derived from the Chronic Care
Model, are associated with HRQOL and optimal manage-
ment in heart failure in primary care. We also studied the
associations between clinical management and HRQOL.
Methods
Design and population
In the period 2005–2006, we performed an observational
study including 72 GPs in 42 primary care practices in the
Netherlands. The sample of practices accounted for
urbanization rate and types of practice.
GPs received tailored written instructions how to extract a
list of patients with CHF from their electronic medical
record system (EMR). Subsequently, they were asked to
assess whether the patients on the EMR list met the diag-
nostic criteria of the ICPC code K77 (heart failure). This
was to limit the number of false-positive CHF diagnoses.
All patients with a diagnosis of CHF according to the GP
were eligible to be included. Reasons for exclusion were:
terminal illness, Dutch language problems, mental
impairment, or other practical reasons to not include the
patient in this study. GPs sent their patients (893 in total)
an invitational letter, asking for informed consent. Con-
sent was received from 511 patients. Ethical approval for
this study was waived by the ethics committee Arnhem-
Nijmegen.
Outcome measures
HRQOL was measured through the Dutch version of the
Minnesota Living with Heart Failure Questionnaire [23].
This disease-specific 21-item questionnaire has been
widely used in clinical trials and shows documented reli-
ability, validity and sensitivity [23,24]. The instrument
uses a six-point Likert scale, indicating to what extent CHF
influences patient's life during the month previous to
measurement (ranging from 0: no influence, to 5: HF
influenced the patient's life to a very high extent). If an
item was not applicable to a patient, a '0' was recorded.
Per patient, a total score was computed by summing the
21 items (summary range 0–105), with the lower scores
reflecting better HRQOL. We imputed missing values (per
person mean substitution). The scale ratings were
excluded if less than 16 answers per patient were entered.
Internal consistency reliability, using Chronbach's alpha
was 0.94.
Our second outcome measure was the sum score on eight
measures of lifestyle advice to CHF patients [5-7] (see
Table 1; measurements at individual patient level). Here,
Chronbach's alpha was 0.86. A patient receives a score
between 0 and 8, as each indicator received either a score
of '1' or '0'. All patient items were assessed through
printed questionnaires that were sent to 461 patients
around the date of medical record data collection. All
patients that handed in a written informed consent
received a questionnaire, unless the patient had died in
the meantime, or there were reasons for exclusion as
judged by the GP. After three weeks reminders were sent.
Questionnaires were received from 385 patients (83.5%
response rate).
Our third outcome measure was a dichotomous variable
that indicated whether a patient had received optimal
pharmacological treatment. This variable was based on a
global adherence index (GAI) for key-pharmacological
recommendations [5-7]. For each patient, this index indi-BMC Health Services Research 2009, 9:104 http://www.biomedcentral.com/1472-6963/9/104
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cated the proportion of evidence-based recommendations
followed by the GP out of the total number of recommen-
dations that applied for that particular patient [25]. The
GAI included the prescription of ACEI (or ARB) for all
patients, β-blockers of proven efficacy in CHF (bisoprolol,
carvedilol or metoprolol) [5-7] in patients with previous
MI or NYHA class ≥ II) and spironolactone (in patients
NYHA class ≥ III). The measure was scored '1' for each
individual patient if the patient received all indicated
drugs. Information on pharmacological treatment was
obtained from scrutinizing the patients' records by trained
research staff. Due to limited resources, collection of med-
ical record data was limited to a random sample of a max-
imum of 15 patients per practice.
Independent measures
Organizational characteristics were measured using writ-
ten validated questionnaires for physicians sent to all 72
GPs in our sample. They worked in 49 physician groups in
42 separate practices (response rate 88%). We distin-
guished between general organizational characteristics
such as location of organization, list size, and age and
number of years of experience of physicians and aspects of
structured chronic care including items addressing four of
the domains of the Chronic Care Model [13,14,26]: self-
management support, design of the care delivery system,
decision support, and supportive clinical information sys-
Table 1: characteristics of the patients (N = 357)
Age (mean years, SD) 75.7 (10.2)
Sex (% male) 52.9
NYHA class (% I & II) 73.1
Optimal pharmacological treatment (% yes) 33.1
ACE/ARB (%) 58.3
β-blockers 46.9
Spironolactone 31.0
Lifestyle advice (0 – 8) (mean, SD) 4.4 (2.7)
Heart signs and symptoms (% yes) 58.3
Type of heart disorder 52.8
Medication intake 54.2
Reduced salt and limited fluid intake 37.5
Physical activity 41.6
Flu prevention 91.1
Weighing regularly 54.7
Coping behaviour 42.8
Quality of Life (0 – 105, less is better) (mean, SD) 30.5 (24.8)
Men 26.3 (1.9)
Women 35.5 (2.4)
NYHA class I 15.5 (1.5)
NYHA class II 36.6 (2.4)
NYHA class III 51.5 (2.7)
NYHA class IV 57.4 (11.3)
≤ 75 27.0 (2.3)
> 75 33.5 (2.0)
Table 2: structured care characteristics in 49 physician groups
Characteristic (% yes)
Regular clinical meetings on CHF patients 18.8
Special hours for patients with heart disease 10.4
Agreements with cardiologist on sharing of information and organization of care 24.5
Decision support
• Info materials present for patients regarding guideline adherence 58.5
• Presence of HF protocol in practice 88.6
Delivery system design
• Next appointment made immediately after visit 91.1
• Continuity of care for CHF patients is a high priority 88.9
• Frequency and content of visit are tailored to individual patients 100.0
• Clear tasks and responsibilities practice members 31.8
• Someone who assures that tasks and responsibilities are clearly defined 34.9
• Appointment system facilitates the patient seeing multiple practice employees in a single visit 13.8 #
Self-management support
• Assessment and documentation of self-management needs and activities is part of the treatment 84.4
• Patient involvement in treatment plans 86.7
• Someone responsible for self-management in patients with HF 16.3
Clinical information systems
• Reminders build in EMR 25.0
• Reminders are periodically received 11.1
• Information related to the needs of HF patients is provided to practice members 16.7
Sum score structured care characteristics (0–17; mean, SD) 8.3 (2.7)
# significant association with lifestyle advice: β = 1.0; 95% CI (0.0, 2.0); p = 0.04BMC Health Services Research 2009, 9:104 http://www.biomedcentral.com/1472-6963/9/104
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tem (Table 2). Self-management support emphasizes
patients' responsibility in managing their health through
such strategies as resolving problems, and devising action
plans. An active delivery system design facilitates planned
patient visits and includes the existence of practice teams
with a division of tasks. Decision support enhances adher-
ence to evidence-based guidelines, incorporated in daily
practice decision making through system reminders and/
or prompts. They are reinforced through provider training
or other decision support mechanisms. Clinical informa-
tion systems provide access to patient data and can be
used to plan individual patient's care, identify relevant
subpopulations for care, and monitor the performance of
health care providers. Items are based on the elements as
specified in the Assessment of Chronic Illness Care instru-
ment [27], which was translated from English to Dutch by
a bilingual researcher, followed by back-translation from
Dutch to English by a second bilingual researcher. Dis-
crepancies between the original questionnaire items and
the back-translation were identified and solved with a
third bilingual researcher. All researchers were familiar
with the theoretical constructs. Items were either dichoto-
mous (e.g. "Is there someone responsible for self-manage-
ment in patients with CHF in your practice?"), or based on
a five-point Likert scale ranging from 'always' to 'never'
(e.g. "Are CHF patients involved in making treatment
plans?"), which were rescaled to a binary variable ('never'
and 'rarely' = 0; 'regularly', 'usually', and 'always' = 1).
Items were excluded if they were missing in >10% of cases.
The remaining items are listed in Table 2. Since the inter-
nal consistency as measured by Chronbach's alpha of the
scales varied widely (ranging from 0.27 to 0.75), we used
the single items in the analyses. In addition, we calculated
a sum score of the structured care characteristics, ranging
from 0 to 17.
Data-analysis
Patients without a date of diagnosis or medical record
data were excluded from the study (N = 121). Thirty three
(6.4%) patients had died between inclusion and medical
record abstraction. In total, 154 patients were excluded,
leaving 357 patients for this study. Excluded patients did
not differ significantly from included patients with respect
to age, sex, and NYHA class.
We analyzed data on the patient level. Patient data was
merged with physician data. In case several GPs were see-
ing the same patients their data were aggregated before
merging. In case of continuous variables, means were cal-
culated across physicians within the same physician group
(one or more physicians seeing the same panel of
patients). If disagreements existed between physicians
regarding the dichotomous variables, such as presence of
a HF protocol in practice, they were contacted for clarifi-
cation. In a few remaining cases, scores higher then '0',
were scored '1'. The aggregated GP data were then merged
with the patient data set, in such a way that each patient
treated by more than one physician had the same value on
these particular GP variables. Descriptive analyses of
patients' characteristics were performed (Table 1). For the
description of physician characteristics, means and pro-
portions were calculated across physician practice groups.
Bivariate associations were explored between the struc-
tured care characteristics on the one hand, and manage-
ment and HRQOL on the other, using random-coefficient
regression analyses for the HRQOL and the lifestyle advice
outcomes, and random-coefficient logistic regression
analyses for the dichotomous outcome (optimal pharma-
cological treatment). If items showed hardly any variation
between physicians (<10%), they were excluded from the
bivariate analyses. Random-coefficient analyses were per-
formed to correct for the clustering effect of the design,
patients (level 1) were clustered within physician groups
(level 2). For statistically significant associations (P < .05),
we repeated the analyses using patient age, gender and –
in case of the lifestyle management and HRQOL out-
comes – NYHA class as possible confounders. In addition,
we explored whether optimal pharmacological manage-
ment and lifestyle advice were related to HRQOL in ran-
dom-coefficient regression analyses using the same
confounders. All analyses were performed using SPSS 14,
except for the multi-level logistic regression analyses that
were performed using the Glimmix procedure in SAS for
Windows V8.2.
Results
Patient characteristics
Table 1 shows the characteristics of the patients. 73% of
patients were classified as NYHA I or II. The mean age of
the patients was 75.7 years (SD 10.2), and 52.9% was
male. Around 33% of patients received optimal pharma-
cological treatment, the average number of lifestyle advice
patients received was 4.4 (SD 2.7). The mean HRQOL
score was 30.5. Hence, on average, patients scored 1.45 on
the Likert scales (ranging from 0: no influence, to 5: CHF
influenced the patient's life to a very high extent). As
expected, scores varied by NYHA class; the higher the
NYHA class, the lower the reported HRQOL scores were (P
< .001). Patients above 75 years of age reported lower
HRQOL as compared to patients younger than 75 (P =
.02).
Characteristics of primary care physicians
About 63% of the physician groups were (small) group
practices. The mean age of the GPs across groups was 49.2
years and mean number of years of experience since qual-
ification as a GP was 18.6.BMC Health Services Research 2009, 9:104 http://www.biomedcentral.com/1472-6963/9/104
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Table 2 presents the various physician groups as they
structured their care for CHF patients. The mean sum
score for the structured care characteristics was 8.3 (SD
2.7). Few physician groups (10%) had special hours for
heart disease patients, while around 19% held regular
clinical meetings on CHF. Practice nurses and assistants
were involved in care for cardiovascular risk patients to a
high extent; in 81% they were involved in systematically
determining risk profiles; in 98% they did regular check-
ups of known patients with CHF, and in 56% they were
involved in case-finding. Finally, in 94% of physician
groups they provided patients with oral or written infor-
mation. A 75% of the physician groups had written agree-
ments on when assistants and nurses should ask for
feedback from their GP. A 10% of the groups used stand-
ardized forms for referral to specialized care.
Associations between structured care characteristics and 
HRQOL
No associations were found between the factors presented
in Table 2 and HRQOL. Bivariate analyses showed that in
practices in which someone was responsible for self-man-
agement in patients with CHF, patients reported better
quality of life (β = -9.91, P = .03). Also, in practices in
which materials were provided to practice members
regarding the needs of CHF patients, patients reported
better HRQOL (β = -9.71, P = .03). However, both associ-
ations were not statistically significant when we repeated
the analysis adjusting for patient age, sex and NYHA class
(β = -3.6, P = .27, and β = -3.8, P = .21 respectively).
Associations between clinical treatment and HRQOL
Optimal lifestyle advice was not related to HRQOL,
whereas optimal pharmacological treatment did relate to
HRQOL. Patients who received optimal pharmacological
treatment reported better HRQOL (β = -11.5, P < .0001).
Adding the control variables did not change this relation.
Associations between structured care characteristics and 
optimal treatment
No associations were found between the organizational
factors and optimal pharmacological treatment. In bivari-
ate analyses, it appeared that more lifestyle advice was
given in practices with an appointment system allowing
contact with more than one professional during the
encounter (β = 1.0, P = .04). Patients scored one point
higher on the sum score for lifestyle advice (scale from 0
to 8) compared with patients in practices not allowing for
appointments with several care givers within one visit.
Adding our control variables did not change this relation-
ship.
Discussion
Contrary to the expectation, HRQOL and treatment in
chronic heart failure patients were not consistently associ-
ated with aspects of structured care characteristics of pri-
mary care practices. Our study involved a representative
sample of general practices in the Netherlands. At the time
of the study, no specific arrangements with insurers
existed that may have influenced treatment.
Earlier studies that focused on the relationship between
'structured care principles' and quality of (primary) care
for various other conditions showed mixed results. One
study that examined the chronic care model in preventing
health risk behaviours in primary care found some associ-
ations e.g. between point-of-care reminders, clinical staff
meetings and recommended services [20]. Also, a study in
primary diabetes care found that planned care – the
implementation of practice guidelines, support for self-
management and clinical information systems – was asso-
ciated with improved performance and most metabolic
outcomes in patients on 2-year follow-up [28]. In addi-
tion, a study on the relation between 8 measures of pri-
mary health care orientation and the implementation of
11 elements of chronic care management in 957 US phy-
sician organizations found that 6 of their 8 measures,
including health education activity, were positively asso-
ciated with adoption of chronic care elements [29]. How-
ever, a study that tested whether improvements in care
quality were correlated with changes in the chronic care
model in 17 primary care clinics concluded that despite
implementation of the chronic care model and improve-
ments in quality measures for three chronic conditions,
there were very few significant relations between these
changes [30]. Yet, their diabetes control measures were
significantly associated with both clinical information
systems and decision support. In addition, a cross-sec-
tional study on the association between quality of care
and intensity of three disease management strategies (pro-
vider feedback, reminders, and structured care) found that
more intense disease management strategies predicted
higher scores on many process of care measures, but only
one intermediate outcome and one medication manage-
ment outcome [15].
So, although not conclusive, the studies show some asso-
ciations between structured care and improved manage-
ment of conditions, whereas our study mostly failed to
show associations between structured care principles and
clinical management. Possibly, this may be explained by
variation in outcome measures. The amount of variation
in our outcome measures that could maximally be attrib-
uted to cluster level factors – as measured by the intra-
cluster correlation (ICC) – was for all three study out-
comes smaller than 10% (ranging from 1.5 to 8.2%). The
variation in outcomes at practice level may have been
higher in other studies. Also, both the observational stud-
ies had somewhat larger sample sizes than our study [211,
306]. However, a post hoc sample size calculation forBMC Health Services Research 2009, 9:104 http://www.biomedcentral.com/1472-6963/9/104
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multiple regression analysis revealed that our sample size
gave us 80% power to detect a R2 of 0.049 (for both
HRQOL and lifestyle advice), assuming a type one error
rate of 5% and a maximum of 4 factors in the model. This
is comparable with a effect size for multiple regression f2
of 0.051, which is a small effect according to Cohen
[31,32].
Systematic reviews [19,21,33] on the effectiveness of com-
prehensive disease management programs (though
mainly based on secondary care studies) in improving
clinical outcomes in HF, indicated that chronic care ele-
ments may improve both HF management as well as
QOL. For instance, whereas we failed to find associations
between structured care elements and improved pharma-
cological management, two of the 3 trials McAlister et al.
included in their review that assessed the medications of
proven efficacy, demonstrated greater use of these thera-
pies in the intervention studies. However, these improve-
ments on prescribing do not necessarily seem to be
translated into improvements of QOL. Studies investigat-
ing the relation between pharmacological management
and QOL mostly did not find an association [34,35]. The
fact that we did find a significant relationship between
optimal pharmacological treatment and HRQOL may be
explained by our measure of optimal pharmacological
treatment. This measure indicates whether the patients
received all the indicated drugs, according to guideline
recommendations. However, since patients in lower
NYHA classes need to receive fewer drugs than patients in
higher NYHA classes, it is 'easier' to attain the score 'opti-
mal' for the patients in lower classes, who in general indi-
cate better QOL.
In addition, research suggested that one of the key ele-
ments to success in disease management programs seems
to be an emphasis on patient education and self-manage-
ment [19,21]. These elements help to give patients a sense
of control over their condition and their ability to prevent
deterioration, and therefore may strongly influence QOL
[36]. Several trials showed better adherence to self-man-
agement strategies and improved QOL when patients
received appropriate education [21]. However, a recent
study found that participation in a quality improvement
collaborative for heart failure was associated with better
communication, knowledge, and lower health care use,
but not with better QOL [37]. In bivariate analyses we
found that patients in practices in which a) someone was
responsible for self-management or b) in which materials
were provided to practice members regarding the needs of
HF patients, patients reported better HRQOL. However,
both associations were rather limited in terms of clinical
relevance and not statistically significant when we
repeated the analysis adjusting for patient age, sex and
NYHA class. Since NYHA class is consistently and closely
associated to QOL [4], this presumably points to a selec-
tion effect; it is likely that a certain patient population
(e.g. a higher number of patients in higher NYHA classes)
is selected in certain practices (e.g. the ones who have a
practice member who is responsible for self manage-
ment). There is – however – a wide variety of programs
and interventions that can be labelled 'disease manage-
ment' [22], and therefore it is not always clear what partic-
ular element in such a 'comprehensive program' results in
successful outcomes, which complicates the comparison
of several studies with our results.
Some possible limitations of our study should be noted.
Measuring lifestyle advice, we used self-reported data, as
preventive and counselling activities have been found to
be under recorded in EMRs [38]. However, we cannot rule
out recall bias [36,39], which may have underestimated
our measures. In addition, we did not measure whether
the patient received advice from other caregivers than the
GP, such as the cardiologist, which may have diluted a
possible relationship between lifestyle advice received
from the GP and patient HRQOL. Also, our measure of
optimal pharmacological treatment did not take into
account possible reasons to deviate from the suggestions
in the guidelines such as contra indications and intoler-
ance for drugs, multiple morbidities, or, simply, lack of
robust evidence in case of chronic heart failure with pre-
served systolic function [40,41]. Future studies should
preferably measure these factors – which may have caused
underestimation of rates in our study [42,43]. Finally, we
l i k e  t o  n o t e  t h a t  w e  c a n n o t  c o n c l u d e  t h a t  w e  s h o w e d
causal linkages, as we used a cross-sectional design.
Conclusion
This study is one of very few studies that explore the
importance of structured care factors that may be related
to HRQOL and high quality care in heart failure in a rep-
resentative sample of primary care practices. The presence
of structured care elements varied widely. However, only
few associations were found between the structured care
characteristics and optimal management and HRQOL.
Better insight into the possible relevance of these factors is
of importance to guide the design of future practice mod-
els in primary care that will contribute to high quality
heart failure management, and – ultimately – higher
HRQOL in patients. Future studies may benefit from more
robust study designs, and combining quantitative and
qualitative research methods [44] to disentangle what ele-
ments of disease management are effective and to gain
more insights into possibly mediating or moderating fac-
tors. Also, more information on how to measure struc-
tured chronic care is needed [30], especially in primary
care.BMC Health Services Research 2009, 9:104 http://www.biomedcentral.com/1472-6963/9/104
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